These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16449968)

  • 21. p63: the phantom of the tumor suppressor.
    Finlan LE; Hupp TR
    Cell Cycle; 2007 May; 6(9):1062-71. PubMed ID: 17426453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional regulation of p73 and p63: development and cancer.
    Melino G; Lu X; Gasco M; Crook T; Knight RA
    Trends Biochem Sci; 2003 Dec; 28(12):663-70. PubMed ID: 14659698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of the interleukin 4 receptor alpha gene as a direct target for p73.
    Sasaki Y; Mita H; Toyota M; Ishida S; Morimoto I; Yamashita T; Tanaka T; Imai K; Nakamura Y; Tokino T
    Cancer Res; 2003 Dec; 63(23):8145-52. PubMed ID: 14678968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage.
    Strano S; Monti O; Pediconi N; Baccarini A; Fontemaggi G; Lapi E; Mantovani F; Damalas A; Citro G; Sacchi A; Del Sal G; Levrero M; Blandino G
    Mol Cell; 2005 May; 18(4):447-59. PubMed ID: 15893728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p73 and p63: why do we still need them?
    Blandino G; Dobbelstein M
    Cell Cycle; 2004 Jul; 3(7):886-94. PubMed ID: 15254416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma.
    Ory B; Ramsey MR; Wilson C; Vadysirisack DD; Forster N; Rocco JW; Rothenberg SM; Ellisen LW
    J Clin Invest; 2011 Feb; 121(2):809-20. PubMed ID: 21293058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential regulation of MDR1 transcription by the p53 family members. Role of the DNA binding domain.
    Johnson RA; Shepard EM; Scotto KW
    J Biol Chem; 2005 Apr; 280(14):13213-9. PubMed ID: 15634666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-talks in the p53 family: deltaNp63 is an anti-apoptotic target for deltaNp73alpha and p53 gain-of-function mutants.
    Lanza M; Marinari B; Papoutsaki M; Giustizieri ML; D'Alessandra Y; Chimenti S; Guerrini L; Costanzo A
    Cell Cycle; 2006 Sep; 5(17):1996-2004. PubMed ID: 16931914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential regulation of vitamin D receptor (VDR) by the p53 Family: p73-dependent induction of VDR upon DNA damage.
    Kommagani R; Payal V; Kadakia MP
    J Biol Chem; 2007 Oct; 282(41):29847-54. PubMed ID: 17716971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of two new members of the p53 family, p63 and p73, in extramammary Paget's disease.
    Chen S; Moroi Y; Urabe K; Takeuchi S; Kido M; Hayashida S; Uchi H; Uenotsuchi T; Tu Y; Furue M
    Clin Exp Dermatol; 2008 Aug; 33(5):634-40. PubMed ID: 18627398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.
    Dohn M; Zhang S; Chen X
    Oncogene; 2001 May; 20(25):3193-205. PubMed ID: 11423969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P53 family: at the crossroads in cancer therapy.
    Alsafadi S; Tourpin S; André F; Vassal G; Ahomadegbe JC
    Curr Med Chem; 2009; 16(32):4328-44. PubMed ID: 19754415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The tumor suppressor protein p53 functions similarly to p63 and p73 in activating transcription in vitro.
    Mondal N; Parvin JD
    Cancer Biol Ther; 2005 Apr; 4(4):414-8. PubMed ID: 15846087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential regulation of p63 and p73 expression.
    Waltermann A; Kartasheva NN; Dobbelstein M
    Oncogene; 2003 Aug; 22(36):5686-93. PubMed ID: 12944917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cell type-specific effect of TAp73 isoforms on the cell cycle and apoptosis.
    Holcakova J; Ceskova P; Hrstka R; Muller P; Dubska L; Coates PJ; Palecek E; Vojtesek B
    Cell Mol Biol Lett; 2008; 13(3):404-20. PubMed ID: 18350258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p63 and p73, the ancestors of p53.
    Dötsch V; Bernassola F; Coutandin D; Candi E; Melino G
    Cold Spring Harb Perspect Biol; 2010 Sep; 2(9):a004887. PubMed ID: 20484388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p73 and p63 sustain cellular growth by transcriptional activation of cell cycle progression genes.
    Lefkimmiatis K; Caratozzolo MF; Merlo P; D'Erchia AM; Navarro B; Levrero M; Sbisa' E; Tullo A
    Cancer Res; 2009 Nov; 69(22):8563-71. PubMed ID: 19861536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53.
    Davison TS; Vagner C; Kaghad M; Ayed A; Caput D; Arrowsmith CH
    J Biol Chem; 1999 Jun; 274(26):18709-14. PubMed ID: 10373484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The transcriptional repressor hDaxx potentiates p53-dependent apoptosis.
    Gostissa M; Morelli M; Mantovani F; Guida E; Piazza S; Collavin L; Brancolini C; Schneider C; Del Sal G
    J Biol Chem; 2004 Nov; 279(46):48013-23. PubMed ID: 15339933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the p53 homologues p63 and p73 in multiple simultaneous gastric cancer.
    Tannapfel A; Schmelzer S; Benicke M; Klimpfinger M; Kohlhaw K; Mössner J; Engeland K; Wittekind C
    J Pathol; 2001 Sep; 195(2):163-70. PubMed ID: 11592094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.